Lidocaine: Difference between revisions
Elcatracho (talk | contribs) |
|||
(41 intermediate revisions by 8 users not shown) | |||
Line 1: | Line 1: | ||
''See [[critical care quick reference]] for drug doses by weight.'' | |||
== | ==General== | ||
*Also known internationally as lignocaine | |||
*Type: [[Local anesthetics]]; [[Antiarrhythmics]] | |||
*Dosage Forms: Local injection, transdermal, intravenous, inhaled, viscous | |||
*Common Trade Names: Xylocaine, P-Care, ReadySharp Lidocaine, Xylocard <ref>Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019</ref> | |||
== | ==Adult Dosing== | ||
=== | ===[[Local anesthetics|Local Anesthetic]]=== | ||
*Loading dose = 1-1. | *Maximum without epinephrine: 5mg/kg (max 300mg) | ||
**Additional boluses of 0.5-0. | *Maximum with epinepherine: 7mg/kg (max 500mg) | ||
===[[Arrythmia|Antiarrhythmic]]=== | |||
*Loading dose = 1-1.5mg/kg | |||
**Additional boluses of 0.5-0.75mg/kg q5-10min up to max of 3mg/kg | |||
**If effective start infusion of 2mg/min | **If effective start infusion of 2mg/min | ||
*Indications | |||
**Treatment of ventricular arrhythmias and ectopy | |||
***Considered 2nd-line to [[amiodarone]] for treatment of [[V-fib]] and [[pulseless v-tach]] | |||
==Pediatric Dosing== | |||
===[[Local anesthetics|Local Anesthetic]]=== | |||
*Without epinepherine: 5mg/kg (max 300mg) | |||
*With epinepherine: 7mg/kg (max 500mg) | |||
=== | ===[[Arrythmia|Antiarrhythmic]]=== | ||
''See [[critical care quick reference]] for drug doses by weight.'' | |||
== | ==Special Populations== | ||
* | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: American B, Australia A | ||
** | *Lactation: Not expected to cause any adverse effect <ref>https://www.ncbi.nlm.nih.gov/books/NBK501230/</ref> | ||
*Renal Dosing | |||
**Adult: No adjustment provided in manufacturer's labelling but accumulation of metabolites may be increased in renal dysfunction<ref>Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019</ref> | |||
**Pediatric: No adjustment provided in manufacturer's labelling <ref>Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019</ref> | |||
*Hepatic Dosing | |||
**Adult: Reduce maintenance infusion when used IV (0.75 mg/minute). Monitor concentration.<ref>Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019</ref> | |||
**Pediatric: Use with caution. Reduce dose. <ref>Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019</ref> | |||
== | ==Contraindications== | ||
* | *Allergy to amide anesthetics | ||
** | **Note that these allergies are rare and are often caused by preservative, so a preservative-free formulation may be appropriate | ||
** | **Note that allergy to amide anesthetics does not suggest allergy to ester anesthetics | ||
** | *High SA or AV block (without pacemaker) | ||
* | *Concurrent treatment with Class I anti-dysrhythmic agents | ||
*[[Wolff-Parkinson-White syndrome]] | |||
=== | ==Adverse Reactions== | ||
* | ===Local=== | ||
* | *Dermatologic | ||
**Itching or irritation | |||
**Depigmentation | |||
**Rash/urticaria | |||
**Edema | |||
**Venous inflammation | |||
=== | ===Serious=== | ||
*[[ | *[[Local Anesthetic Systemic Toxicity (LAST)]] | ||
**Rare during infiltration of local anesthetic | |||
**CNS toxicity | |||
***Metallic taste | |||
***Tinnitus | |||
***Tingling of lips | |||
***Dizziness | |||
***Anxiety | |||
***Confusion | |||
***Lethargy | |||
***Loss of consciousness | |||
***Seizures | |||
***Nausea/vomiting | |||
**Cardiovascular toxicity | |||
***Bradycardia | |||
***Decreased myocardial contractility | |||
***Atrioventricular block | |||
***Vasodilation | |||
***Ventricular arrhythmias | |||
***Cardiac arrest | |||
*Bronchospasm | |||
*Respiratory depression or arrest | |||
*Methemoglobinemia | |||
== | ==Pharmacology== | ||
== | *Pharmacokinetics | ||
**Onset of action = 45-90s | |||
**Duration of action = 10-20min (antiarrythmic IV); 30-90 min (subcutaneous) | |||
**Half-life 90 - 120 minutes | |||
***Prolonged in hepatic impairment or congestive heart failure | |||
*Metabolism | |||
**Primarily hepatic | |||
*Excretion | |||
**Urine | |||
*Mechanism of Action | |||
**Class Ib antiarrythmic | |||
***Binds to fast Na channels in inactive state thereby raising the depolarization threshold | |||
***Acts preferentially on ischemic tissue | |||
****Elevates V-fib threshold | |||
****Suppresses ventricular ectopy | |||
**Little effect on vascular tone, contractility, or cardiac output | |||
==Comments== | |||
*Mix lidocaine 1%/epinephrine with sodium bicarbonate 8.4% in 3:1 ratio results in significantly less painful injections. <ref>Vent A et. al Buffered lidocaine 1%/epinephrine 1:100,000 with sodium bicarbonate (sodium hydrogen carbonate) in a 3:1 ratio is less painful than a 9:1 ratio: A double-blind, randomized, placebo-controlled, crossover trial. J Am Acad Dermatol. 2020 Jul;83(1):159-165. doi: 10.1016/j.jaad.2019.09.088. https://pubmed.ncbi.nlm.nih.gov/31958526/ </ref> <ref>SGEM#307: Buff up the lido for the local anesthetic http://thesgem.com/2020/10/sgem307-buff-up-the-lido-for-the-local-anesthetic/</ref> | |||
**Shorter shelf-life due to decreased stability (use within 2 hours in the Vent A study) | |||
*Warming local anesthetics also decreases pain of injection <ref>Hogan, M., vanderVaart, S., Perampaladas, K., Machado, M., Einarson, T. and Taddio, A., 2020. Systematic Review And Meta-Analysis Of The Effect Of Warming Local Anesthetics On Injection Pain.</ref> | |||
*Inject through wound edges whenever possible | |||
**Avoid injecting through intact skin when possible | |||
==See Also== | ==See Also== | ||
*[[ | *[[Local anesthetic systemic toxicity]] | ||
*[[ | *[[Critical care quick reference]] | ||
==References== | |||
<references/> | |||
[[Category: | [[Category:Pharmacology]] | ||
[[Category: | [[Category:Cardiology]] | ||
Latest revision as of 09:22, 1 March 2024
See critical care quick reference for drug doses by weight.
General
- Also known internationally as lignocaine
- Type: Local anesthetics; Antiarrhythmics
- Dosage Forms: Local injection, transdermal, intravenous, inhaled, viscous
- Common Trade Names: Xylocaine, P-Care, ReadySharp Lidocaine, Xylocard [1]
Adult Dosing
Local Anesthetic
- Maximum without epinephrine: 5mg/kg (max 300mg)
- Maximum with epinepherine: 7mg/kg (max 500mg)
Antiarrhythmic
- Loading dose = 1-1.5mg/kg
- Additional boluses of 0.5-0.75mg/kg q5-10min up to max of 3mg/kg
- If effective start infusion of 2mg/min
- Indications
- Treatment of ventricular arrhythmias and ectopy
- Considered 2nd-line to amiodarone for treatment of V-fib and pulseless v-tach
- Treatment of ventricular arrhythmias and ectopy
Pediatric Dosing
Local Anesthetic
- Without epinepherine: 5mg/kg (max 300mg)
- With epinepherine: 7mg/kg (max 500mg)
Antiarrhythmic
See critical care quick reference for drug doses by weight.
Special Populations
- Pregnancy Rating: American B, Australia A
- Lactation: Not expected to cause any adverse effect [2]
- Renal Dosing
- Hepatic Dosing
Contraindications
- Allergy to amide anesthetics
- Note that these allergies are rare and are often caused by preservative, so a preservative-free formulation may be appropriate
- Note that allergy to amide anesthetics does not suggest allergy to ester anesthetics
- High SA or AV block (without pacemaker)
- Concurrent treatment with Class I anti-dysrhythmic agents
- Wolff-Parkinson-White syndrome
Adverse Reactions
Local
- Dermatologic
- Itching or irritation
- Depigmentation
- Rash/urticaria
- Edema
- Venous inflammation
Serious
- Local Anesthetic Systemic Toxicity (LAST)
- Rare during infiltration of local anesthetic
- CNS toxicity
- Metallic taste
- Tinnitus
- Tingling of lips
- Dizziness
- Anxiety
- Confusion
- Lethargy
- Loss of consciousness
- Seizures
- Nausea/vomiting
- Cardiovascular toxicity
- Bradycardia
- Decreased myocardial contractility
- Atrioventricular block
- Vasodilation
- Ventricular arrhythmias
- Cardiac arrest
- Bronchospasm
- Respiratory depression or arrest
- Methemoglobinemia
Pharmacology
- Pharmacokinetics
- Onset of action = 45-90s
- Duration of action = 10-20min (antiarrythmic IV); 30-90 min (subcutaneous)
- Half-life 90 - 120 minutes
- Prolonged in hepatic impairment or congestive heart failure
- Metabolism
- Primarily hepatic
- Excretion
- Urine
- Mechanism of Action
- Class Ib antiarrythmic
- Binds to fast Na channels in inactive state thereby raising the depolarization threshold
- Acts preferentially on ischemic tissue
- Elevates V-fib threshold
- Suppresses ventricular ectopy
- Little effect on vascular tone, contractility, or cardiac output
- Class Ib antiarrythmic
Comments
- Mix lidocaine 1%/epinephrine with sodium bicarbonate 8.4% in 3:1 ratio results in significantly less painful injections. [7] [8]
- Shorter shelf-life due to decreased stability (use within 2 hours in the Vent A study)
- Warming local anesthetics also decreases pain of injection [9]
- Inject through wound edges whenever possible
- Avoid injecting through intact skin when possible
See Also
References
- ↑ Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019
- ↑ https://www.ncbi.nlm.nih.gov/books/NBK501230/
- ↑ Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019
- ↑ Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019
- ↑ Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019
- ↑ Lidocaine. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Accessed March 15, 2019
- ↑ Vent A et. al Buffered lidocaine 1%/epinephrine 1:100,000 with sodium bicarbonate (sodium hydrogen carbonate) in a 3:1 ratio is less painful than a 9:1 ratio: A double-blind, randomized, placebo-controlled, crossover trial. J Am Acad Dermatol. 2020 Jul;83(1):159-165. doi: 10.1016/j.jaad.2019.09.088. https://pubmed.ncbi.nlm.nih.gov/31958526/
- ↑ SGEM#307: Buff up the lido for the local anesthetic http://thesgem.com/2020/10/sgem307-buff-up-the-lido-for-the-local-anesthetic/
- ↑ Hogan, M., vanderVaart, S., Perampaladas, K., Machado, M., Einarson, T. and Taddio, A., 2020. Systematic Review And Meta-Analysis Of The Effect Of Warming Local Anesthetics On Injection Pain.